Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Chevron reported a year-over-year drop in earnings, even as production rose. This article breaks down why, what it me...
MoneyHero fans will be watching the 2025 earnings with a keen eye for growth, margins, and the companys path to profi...
Microsoft is not shrinking its ambitions. In this deep dive, we explore how the tech giant aims to reset its gaming d...
Oracle just fresh 52-week lows as a credit downgrade highlights the tension between expensive AI infrastructure and c...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
Netflix walked away from a blockbuster deal, but that decision opens two compelling paths for investors. This article...
A fund just opened million in Trustmark shares signals conviction, but it isn’t a guaranteed win. This guide explains...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...